Article

The Cerebrospinal Fluid Management Market is projected to grow from USD 671.17 million in 2024 to USD 1,001.28 million by 2032, achieving a CAGR of 5.18% from 2025 to 2032. Key factors driving this growth include the increasing prevalence of neurological disorders, a rising aging population, and a surge in trauma cases.

Hospitals are the primary end-users, with CSF shunts and valves dominating the market. North America is the leading region, followed by Europe and Asia-Pacific, which is experiencing rapid growth due to healthcare investments and rising disease burdens. Technological advancements, including AI integration, are enhancing diagnostic and treatment capabilities in cerebrospinal fluid management.